Department of Psychiatry, Division of Child and Adolescent Psychiatry, Case Western Reserve University, Cleveland, Ohio, USA.
J Clin Psychiatry. 2010 Dec;71(12):1664-72. doi: 10.4088/JCP.09m05859yel. Epub 2010 Oct 5.
The aim of the Longitudinal Assessment of Manic Symptoms (LAMS) study is to examine differences in psychiatric symptomatology, diagnoses, demographics, functioning, and psychotropic medication exposure in children with elevated symptoms of mania (ESM) compared to youth without ESM. This article describes the initial demographic information, diagnostic and symptom prevalence, and medication exposure for the LAMS cohort that will be followed longitudinally.
Guardians of consecutively ascertained new outpatients 6 to 12 years of age presenting for treatment at one of 10 university-affiliated mental health centers were asked to complete the Parent General Behavior Inventory-10-Item Mania Scale (PGBI-10M). Patients with scores ≥ 12 on the PGBI-10M (ESM+) and a matched sample of patients who screened negative (ESM-) were invited to participate. Patients were enrolled from December 13, 2005, to December 18, 2008.
707 children (621 ESM+, 86 ESM-; mean [SD] age = 9.4 [2.0] years) were evaluated. The ESM+ group, compared to the ESM- group, more frequently met DSM-IV criteria for a mood disorder (P < .001), bipolar spectrum disorders (BPSD; P < .001), and disruptive behavior disorders (P < .01). Furthermore, they showed poorer overall functioning and more severe manic, depressive, attention-deficit/hyperactivity, disruptive behavioral, and anxiety symptoms. Nevertheless, rates of BPSD were relatively low in the ESM+ group (25%), with almost half of these BPSD patients (12.1% of ESM+ patients) meeting DSM-IV criteria for bipolar disorder not otherwise specified. ESM+ children with BPSD had significantly more of the following: current prescriptions for antipsychotics, mood stabilizers, and anticonvulsants (P < .001 for each); psychiatric hospitalizations (P < .001); and biological parents with elevated mood (P = .001 for mothers, P < .013 for fathers). ESM+ children with BPSD were also lower functioning compared to ESM+ children without BPSD.
Although ESM+ was associated with higher rates of BPSD than ESM-, 75% of ESM+ children did not meet criteria for BPSD. Results suggest that longitudinal assessment is needed to examine which factors are associated with diagnostic evolution to BPSD in children with elevated symptoms of mania.
纵向评估躁狂症状(LAMS)研究的目的是检查在有升高的躁狂症状(ESM)的儿童与没有 ESM 的青年之间,在精神病学症状、诊断、人口统计学、功能和精神药物暴露方面的差异。本文描述了将进行纵向随访的 LAMS 队列的初始人口统计学信息、诊断和症状流行率以及药物暴露情况。
连续确定的新门诊患者的监护人,年龄在 6 至 12 岁之间,在 10 个大学附属心理健康中心之一接受治疗,要求他们完成父母一般行为量表-10 项躁狂量表(PGBI-10M)。得分≥12 分的患者(ESM+)和筛检阴性的匹配患者(ESM-)被邀请参加。患者于 2005 年 12 月 13 日至 2008 年 12 月 18 日入组。
共评估了 707 名儿童(621 名 ESM+,86 名 ESM-;平均[SD]年龄=9.4[2.0]岁)。与 ESM-组相比,ESM+组更频繁地符合 DSM-IV 心境障碍(P<0.001)、双相谱系障碍(BPSD;P<0.001)和破坏性行为障碍(P<0.01)标准。此外,他们表现出更差的总体功能和更严重的躁狂、抑郁、注意力缺陷/多动、破坏性行为和焦虑症状。然而,ESM+组的 BPSD 发生率相对较低(25%),其中近一半的 BPSD 患者(ESM+患者的 12.1%)符合 DSM-IV 未特指的双相障碍标准。有 BPSD 的 ESM+儿童明显有更多以下情况:当前抗精神病药、心境稳定剂和抗惊厥药处方(每项 P<0.001);精神病院住院治疗(P<0.001);以及情绪升高的生物父母(母亲 P=0.001,父亲 P<0.013)。与没有 BPSD 的 ESM+儿童相比,有 BPSD 的 ESM+儿童的功能也较差。
尽管 ESM+与 BPSD 的发生率高于 ESM-相关,但 75%的 ESM+儿童不符合 BPSD 标准。结果表明,需要进行纵向评估,以检查哪些因素与有升高的躁狂症状的儿童中 BPSD 的诊断演变相关。